Intuitive Surgical, Inc. $ISRG Shares Purchased by HighPoint Advisor Group LLC

HighPoint Advisor Group LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 112.6% during the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 15,205 shares of the medical equipment provider’s stock after buying an additional 8,052 shares during the period. HighPoint Advisor Group LLC’s holdings in Intuitive Surgical were worth $6,800,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Rossmore Private Capital grew its holdings in Intuitive Surgical by 2.0% in the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock valued at $446,000 after purchasing an additional 20 shares during the period. Activest Wealth Management grew its stake in Intuitive Surgical by 21.7% in the 3rd quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock valued at $50,000 after acquiring an additional 20 shares during the period. Vertex Planning Partners LLC increased its holdings in Intuitive Surgical by 2.3% in the 2nd quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock worth $498,000 after acquiring an additional 21 shares in the last quarter. Accredited Investors Inc. increased its holdings in Intuitive Surgical by 2.0% in the 3rd quarter. Accredited Investors Inc. now owns 1,060 shares of the medical equipment provider’s stock worth $474,000 after acquiring an additional 21 shares in the last quarter. Finally, Evermay Wealth Management LLC raised its position in Intuitive Surgical by 3.1% during the second quarter. Evermay Wealth Management LLC now owns 731 shares of the medical equipment provider’s stock worth $397,000 after acquiring an additional 22 shares during the period. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In related news, EVP Myriam Curet sold 126 shares of the company’s stock in a transaction that occurred on Thursday, January 29th. The shares were sold at an average price of $520.02, for a total transaction of $65,522.52. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Gary S. Guthart sold 2,800 shares of the firm’s stock in a transaction that occurred on Tuesday, January 27th. The shares were sold at an average price of $531.52, for a total transaction of $1,488,256.00. Following the completion of the sale, the director directly owned 15,720 shares in the company, valued at approximately $8,355,494.40. This trade represents a 15.12% decrease in their position. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 73,616 shares of company stock valued at $40,929,575. 0.70% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

Several research analysts recently weighed in on ISRG shares. Wall Street Zen upgraded shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Saturday, January 17th. Wells Fargo & Company increased their target price on Intuitive Surgical from $600.00 to $654.00 and gave the company an “overweight” rating in a report on Friday, December 12th. Raymond James Financial raised their target price on Intuitive Surgical from $603.00 to $615.00 and gave the company an “outperform” rating in a research report on Friday, January 23rd. BTIG Research reiterated a “buy” rating and set a $616.00 price target on shares of Intuitive Surgical in a research report on Friday, January 23rd. Finally, Robert W. Baird decreased their price objective on Intuitive Surgical from $655.00 to $645.00 and set an “outperform” rating on the stock in a report on Friday, January 23rd. Two equities research analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average target price of $620.41.

Intuitive Surgical Trading Down 0.1%

Shares of ISRG opened at $478.49 on Thursday. The firm has a market cap of $171.53 billion, a P/E ratio of 60.65, a price-to-earnings-growth ratio of 3.72 and a beta of 1.65. Intuitive Surgical, Inc. has a 12-month low of $425.00 and a 12-month high of $609.08. The company’s 50-day moving average price is $553.29 and its 200 day moving average price is $510.97.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 EPS for the quarter, topping analysts’ consensus estimates of $2.27 by $0.26. The company had revenue of $2.87 billion for the quarter, compared to analysts’ expectations of $2.72 billion. Intuitive Surgical had a return on equity of 15.06% and a net margin of 28.38%.The firm’s revenue was up 18.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $2.21 earnings per share. Equities research analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

About Intuitive Surgical

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.